Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the correct purchasers needs the drug will fail to reach its intended market value. This book is based on an accredited course in this area out of The European Market Access University Diploma (EMAUD) and affiliated with Aix Marseille University.

Key Features:

• The first guide to market access for pharmaceuticals based on tested...